1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

Biosimilars | South korea | Imerys Graphite And Carbon Switzerland Sa

Imerys Graphite And Carbon Switzerland Sa South korea

Back

Download Excel File

Show entries

Search:

Approval Date	Withdrawal Date	Active Substance	Generic Brand Name	Biosimilar Brand Name	Dosage Form	Strength	Unit	Disease	Therapeutic Area	Company	Country	Remarks

Approval Date	Withdrawal Date	Active Substance	Generic Brand Name	Biosimilar Brand Name	Dosage Form	Strength	Unit	Disease	Therapeutic Area	Company	Country	Remarks
No data available in table

Showing 0 to 0 of 0 entries

PreviousNext

Cookies & Privacy

This website uses ‘cookies’ to operate our site and personalize your digital experience. By continuing to browse this website, you agree to the terms outlined in our Privacy Policy, Cookies Policy

Imerys Graphite And Carbon Switzerland Sa South korea

Advance Filter

Last Update : 2012 To Nov 2024

Cookies & Privacy

Select cookies to accept